Role of cytokines in head and neck squamous cell carcinoma (Q36613975)

15 August 2017

1 reference

title

Role of cytokines in head and neck squamous cell carcinoma (English)

1 reference

15 August 2017

Ralph Pries

1 reference

15 August 2017

Stefan Nitsch

series ordinal

1 reference

15 August 2017

Barbara Wollenberg

series ordinal

1 reference

15 August 2017

publication date

1 September 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

published in

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

1195-1203

1 reference

Duration but not intensity of alcohol and tobacco exposure predicts p16INK4A homozygous deletion in head and neck squamous cell carcinoma

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Recent new approaches to the treatment of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Molecular introduction to head and neck cancer (HNSCC) carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

What is transforming growth factor-beta (TGF-beta)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Cytokine expression by head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Cytokines in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Controlling cytokine signaling by constitutive inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Targeting key steps in metastatic tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Chemokines provide the sustained inflammatory bridge between innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

The greater chemotactic network for lymphocyte trafficking: chemokines and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Dendritic cell trafficking: more than just chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Targeting chemoattractant receptors in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Human mast cell chemokines receptors: implications for mast cell tissue localization in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Down-regulation of CXCL5 inhibits squamous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Production of nitric oxide and transforming growth factor-beta in developing and adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Defects in the interferon-gamma and interleukin-12 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Gene therapy--phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Cytokines IL-1α, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Nuclear factor-kappa B and cancer: its role in prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Antiproliferative effects of IFN-alpha correlate with the downregulation of nuclear factor-kappa B in human Burkitt lymphoma Daudi cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Activation and signaling of the p38 MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Aging, longevity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Clinical results of leukocyte interferon-induced tumor regression in resistant human metastatic cancer resistant to chemotherapy and/or radiotherapy-pulse therapy schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

ALCOHOL AND TOBACCO CONSUMPTION IN CANCER OF THE MOUTH, PHARYNX, AND LARYNX

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.9.1195

10.1586/14737140.6.9.1195

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference